The aim of this randomized placebo-controlled 5-arm clinical trial is to evaluate the effect
of combined anabolic interventions compared to single or placebo interventions on physical
performance in community-dwelling (pre)sarcopenic elderly (≥ 65 years) and to determine the
underlying mechanisms of action. Important secondary outcome measures are muscle mass, muscle
strength, compliance to the interventions (exercise program, protein and omega-3
supplementation) and functional, cognitive and nutritional status.
Phase:
N/A
Details
Lead Sponsor:
Universitaire Ziekenhuizen Leuven
Collaborators:
KU Leuven Nestlé Health Science Belgium VISTA-Life